Advancements and Utilizations of Scaffolds in Tissue Engineering and Drug Delivery
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
The drug development process requires a thorough understanding of the scaffold and its three-dimensional structure. Scaffolding is a technique for tissue engineering and the formation of contemporary functioning tissues. Tissue engineering is sometimes referred to as regenerative medicine. They also ensure that drugs are delivered with precision. Information regarding scaffolding techniques, scaffolding kinds, and other relevant facts, such as 3D nanostructuring, are discussed in depth in this literature. They are specific and demonstrate localized action for a specific reason. Scaffold's acquisition nature and flexibility make it a new drug delivery technology with good availability and structural parameter management.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Current drug targets - 24(2023), 1 vom: 10., Seite 13-40 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chauhan, Akash [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3D nanostructuring |
|---|
| Anmerkungen: |
Date Completed 10.03.2023 Date Revised 21.03.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1389450123666221011100235 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347370500 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347370500 | ||
| 003 | DE-627 | ||
| 005 | 20231226033647.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389450123666221011100235 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1157.xml |
| 035 | |a (DE-627)NLM347370500 | ||
| 035 | |a (NLM)36221880 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chauhan, Akash |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advancements and Utilizations of Scaffolds in Tissue Engineering and Drug Delivery |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.03.2023 | ||
| 500 | |a Date Revised 21.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a The drug development process requires a thorough understanding of the scaffold and its three-dimensional structure. Scaffolding is a technique for tissue engineering and the formation of contemporary functioning tissues. Tissue engineering is sometimes referred to as regenerative medicine. They also ensure that drugs are delivered with precision. Information regarding scaffolding techniques, scaffolding kinds, and other relevant facts, such as 3D nanostructuring, are discussed in depth in this literature. They are specific and demonstrate localized action for a specific reason. Scaffold's acquisition nature and flexibility make it a new drug delivery technology with good availability and structural parameter management | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 3D nanostructuring | |
| 650 | 4 | |a Scaffolds | |
| 650 | 4 | |a bioavailability | |
| 650 | 4 | |a drug development | |
| 650 | 4 | |a regenerative medicines | |
| 650 | 4 | |a tissue engineering | |
| 700 | 1 | |a Alam, Md Aftab |e verfasserin |4 aut | |
| 700 | 1 | |a Kaur, Awaneet |e verfasserin |4 aut | |
| 700 | 1 | |a Malviya, Rishabha |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug targets |d 2000 |g 24(2023), 1 vom: 10., Seite 13-40 |w (DE-627)NLM113669291 |x 1873-5592 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:1 |g day:10 |g pages:13-40 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389450123666221011100235 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 1 |b 10 |h 13-40 | ||